OmniAb (OABI) Long-Term Deferred Tax (2021)

OmniAb's (OABI) quarterly Long-Term Deferred Tax came in at $597270.0 in Q2 2021.

OmniAb (OABI) Long-Term Deferred Tax (2021) Analysis & Trends

OmniAb (OABI) has 1 years of Long-Term Deferred Tax data on file, last reported at $597270.0 in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 OmniAb 261.62 Mn 212.55 Mn 14.41 Mn

Historic Data

Download Data
DateValue
Jun 30, 2021 597,270.00